# Takahito Moriyama

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/takahito-moriyama/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,205 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 26 |
| i10-index | 64 |
| Last Known Institution | FIND |
| OpenAlex ID | https://openalex.org/A5006663529 |
| ORCID iD | 0000-0002-9459-4924 |
| Works | 154 |

## Researcher papers

Showing 12 of 14.

- [Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan](https://scholariq.org/papers/prognosis-in-iga-nephropathy-30-year-analysis-of-1-012-patients-at-a-single/)
- [Caveolar Endocytosis Is Critical for BK Virus Infection of Human Renal Proximal Tubular Epithelial Cells](https://scholariq.org/papers/caveolar-endocytosis-is-critical-for-bk-virus-infection-of-human-renal-proximal/)
- [Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults](https://scholariq.org/papers/effect-of-single-dose-rituximab-on-steroid-dependent-minimal-change-nephrotic/)
- [Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation](https://scholariq.org/papers/latent-iga-deposition-from-donor-kidney-is-the-major-risk-factor-for-recurrent/)
- [Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease](https://scholariq.org/papers/switching-from-allopurinol-to-febuxostat-for-the-treatment-of-hyperuricemia-and/)
- [Effect of Single-Dose Rituximab on Primary Glomerular Diseases](https://scholariq.org/papers/effect-of-single-dose-rituximab-on-primary-glomerular-diseases/)
- [Clinical and histological features and therapeutic strategies for IgA nephropathy](https://scholariq.org/papers/clinical-and-histological-features-and-therapeutic-strategies-for-iga/)
- [Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: A randomized controlled study](https://scholariq.org/papers/febuxostat-improves-endothelial-function-in-hemodialysis-patients-with/)
- [Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis](https://scholariq.org/papers/effects-of-long-term-treatment-with-mizoribine-in-patients-with-proliferative/)
- [Intracellular trafficking pathway of BK Virus in human renal proximal tubular epithelial cells](https://scholariq.org/papers/intracellular-trafficking-pathway-of-bk-virus-in-human-renal-proximal-tubular/)
- [Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis](https://scholariq.org/papers/hyperuricemia-as-a-predictive-marker-for-progression-of-nephrosclerosis-clinical/)
- [Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria](https://scholariq.org/papers/effect-of-hematuria-on-the-outcome-of-immunoglobulin-a-nephropathy-with/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [FIND](https://scholariq.org/institutions/find/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.